Filing Details

Accession Number:
0001883850-24-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-01 16:00:53
Reporting Period:
2024-01-02
Accepted Time:
2024-05-01 16:00:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226690 George Yancopoulos 777 Old Saw Mill River Road
Tarrytown NY 10591
Bd. Co-Chair, President & Cso Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-02 16,848 $900.00 180,000 No 4 S Indirect By Trust for Chldn.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust for Chldn.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 752,486 Direct
Common Stock 5,889 Indirect By 401(k) Plan
Common Stock 121,071 Indirect by 2022 GRAT I
Common Stock 158,410 Indirect by 2022 GRAT II
Footnotes
  1. Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022.
  2. As investment trustee of trusts for the benefit of the reporting person's children.